DSGN Competitors & Alternatives
Compare Design Therapeutics Inc with similar stocks in the same industry
Biotechnology
DSGN
Main Stock$10.59
Tradestie Score
55
Market Cap
$386.68M
Analyst Upside
+105.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$19.05
|
$748.90M | - | 54 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$25.61
|
$718.62M | 10.3 | 47 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$20.51
|
$715.25M | - | 57 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$125.92
|
$699.30M | - | 74 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$5.93
|
$688.47M | - | 50 | Compare |
|
ANL
ANL
|
$10.94
|
$685.19M | - | 68 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.81
|
$665.30M | 11.5 | 63 | Compare |
More DSGN Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry